Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study

Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study

Summary: Few studies have reported the real‐world use of both romiplostim and eltrombopag in immune thrombocytopenia (ITP). TRAIT was a retrospective observational study aimed to evaluate the platelet responses and adverse effects associated with the use of these thrombopoietin receptor agonists (TP...

Full description

Bibliographic Details
Main Authors: Cooper, N, Scully, M, Percy, C, Nicolson, PLR, Lowe, G, Bagot, CN, Thachil, J, Grech, H, Nokes, T, Hill, QA, Bradbury, C, Talks, K, Dutt, T, Evans, G, Pavord, S, Wexler, S, Charania, A, Collington, SJ, Ervin, A, Ramscar, N, Provan, D
Format: Journal article
Language:English
Published: Wiley 2024

Similar Items

Similar Items